InsidersTradesSigma
Track the GENPACT LIMITED share price and the full insider trade history of the company, a listed equity based in United States. Shares trade on the US market, under the oversight of SEC (Form 4). Market capitalisation: €6.1bn. The latest transaction was reported on 19 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: ANIL NANDURU. All data is openly available.
Analysts rate GENPACT LIMITED Buy (bullish), based on 11 analysts. Average price target: US$42.18.
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI analysis generation is paused.
5 of 5 declarations
Genpact Limited is a global professional services firm that provides business process management and technology solutions. It is listed on NASDAQ under the ticker symbol GNTX.